95 related articles for article (PubMed ID: 11921395)
1. Functional mimicry of a discontinuous antigenic site by a designed synthetic peptide.
Villén J; Borràs E; Schaaper WM; Meloen RH; Dávila M; Domingo E; Giralt E; Andreu D
Chembiochem; 2002 Mar; 3(2-3):175-82. PubMed ID: 11921395
[TBL] [Abstract][Full Text] [Related]
2. Synthetic peptides as functional mimics of a viral discontinuous antigenic site.
Villén J; Borràs E; Schaaper WM; Meloen RH; Dávila M; Domingo E; Giralt E; Andreu D
Biologicals; 2001; 29(3-4):265-9. PubMed ID: 11851326
[TBL] [Abstract][Full Text] [Related]
3. The structure and antigenicity of a type C foot-and-mouth disease virus.
Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
[TBL] [Abstract][Full Text] [Related]
4. Mapping of antigenic sites of foot-and-mouth disease virus serotype Asia 1 and relationships with sites described in other serotypes.
Grazioli S; Fallacara F; Brocchi E
J Gen Virol; 2013 Mar; 94(Pt 3):559-569. PubMed ID: 23197575
[TBL] [Abstract][Full Text] [Related]
5. Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus.
Asfor AS; Upadhyaya S; Knowles NJ; King DP; Paton DJ; Mahapatra M
J Gen Virol; 2014 May; 95(Pt 5):1104-1116. PubMed ID: 24584474
[TBL] [Abstract][Full Text] [Related]
6. Expression of a foot-and-mouth disease virus immunodominant epitope by a filamentous bacteriophage vector.
Kim YJ; Lebreton F; Kaiser C; Crucière C; Rémond M
Arch Virol; 2004 Feb; 149(2):365-77. PubMed ID: 14745601
[TBL] [Abstract][Full Text] [Related]
7. Towards a multi-site synthetic vaccine to foot-and-mouth disease: addition of discontinuous site peptide mimic increases the neutralization response in immunized animals.
Villén J; de Oliveira E; Núñez JI; Molina N; Sobrino F; Andreu D
Vaccine; 2004 Sep; 22(27-28):3523-9. PubMed ID: 15315831
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of neutralizing monoclonal antibodies against FMDV serotype O with synthetic peptide antigen.
Ma L; Liu YS; Ding YZ; Chen HT; Zhou JH; Liu WQ; Wang M; Zhang J
Hybridoma (Larchmt); 2010 Oct; 29(5):409-12. PubMed ID: 21050041
[TBL] [Abstract][Full Text] [Related]
9. Improved mimicry of a foot-and-mouth disease virus antigenic site by a viral peptide displayed on beta-galactosidase surface.
Benito A; Mateu MG; Villaverde A
Biotechnology (N Y); 1995 Aug; 13(8):801-4. PubMed ID: 9634810
[TBL] [Abstract][Full Text] [Related]
10. Cyclic peptides as conformationally restricted models of viral antigens: application to foot-and-mouth disease virus.
Valero ML; Camarero JA; Adeva A; Verdaguer N; Fita I; Mateu MG; Domingo E; Giralt E; Andreu D
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):133-40. PubMed ID: 9346844
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the immune response against mixotope peptide libraries from a main antigenic site of foot-and-mouth disease virus.
Oliveira Ed; Jiménez-Clavero MA; Núñez JI; Sobrino F; Andreu D
Vaccine; 2005 Apr; 23(20):2647-57. PubMed ID: 15780448
[TBL] [Abstract][Full Text] [Related]
12. Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease.
Harmsen MM; van Solt CB; Fijten HP; van Keulen L; Rosalia RA; Weerdmeester K; Cornelissen AH; De Bruin MG; Eblé PL; Dekker A
Vet Microbiol; 2007 Mar; 120(3-4):193-206. PubMed ID: 17127019
[TBL] [Abstract][Full Text] [Related]
13. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
[TBL] [Abstract][Full Text] [Related]
15. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
[TBL] [Abstract][Full Text] [Related]
16. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
[TBL] [Abstract][Full Text] [Related]
18. [Antigenic structure of foot-and-mouth virus. IV. Synthesis and immunogenic properties of new fragments of the VP1 protein of food-and-mouth virus strain A22].
Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Lugovskoĭ AA; Driagalin NN; Ivaniushchenkov VN
Bioorg Khim; 1989 Sep; 15(9):1193-205. PubMed ID: 2556150
[TBL] [Abstract][Full Text] [Related]
19. The potential of retro-inverso peptides as synthetic vaccines.
Van Regenmortel MH; Guichard G; Benkirane N; Briand JP; Muller S; Brown F
Dev Biol Stand; 1998; 92():139-43. PubMed ID: 9554267
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
